McKeown; Michael R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for McKeown; Michael R..The latest application filed is for "combination therapy for cancer using bromodomain and extra-terminal (bet) protein inhibitors".

Company Profile

4.8.10

McKeown; Michael R. - Brookline MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Combination therapy for cancer using bromodomain and extra-terminal (BET) protein inhibitors Grant 11,446,309 - Bradner , et al. September 20, 2	2022-09-20
Combination Therapy For Cancer Using Bromodomain And Extra-terminal (bet) Protein Inhibitors App 20210100813 - Bradner; James E. ; et al.	2021-04-08
Uses of diazepane derivatives Grant 10,793,571 - Bradner , et al. October 6, 2	2020-10-06
Methods of stratifying patients for treatment with retinoic acid receptor-alpha agonists Grant 10,697,025 - Chen , et al. June 30, 2	2020-06-30
Methods of stratifying patients for treatment with retinoic acid receptor-alpha agonists Grant 10,167,518 - Chen , et al. J	2019-01-01
Methods Of Stratifying Patients For Treatment With Retinoic Acid Receptor-alpha Agonists App 20180187271 - Chen; Mei W. ; et al.	2018-07-05
Inhibitors of transcription factors and uses thereof Grant 9,975,896 - Marineau , et al. May 22, 2	2018-05-22
Methods Of Stratifying Patients For Treatment With Retinoic Acid Receptor-alpha Agonists App 20180087115 - Chen; Mei Wei ; et al.	2018-03-29
Methods of stratifying patients for treatment with retinoic acid receptor-alpha agonists Grant 9,845,508 - Chen , et al. December 19, 2	2017-12-19
Diazepane derivatives and uses thereof Grant 9,695,172 - Bradner , et al. July 4, 2	2017-07-04
Pyrrol-1-yl benzoic acid derivatives useful as myc inhibitors Grant 9,567,301 - Bradner , et al. February 14, 2	2017-02-14
Uses Of Diazepane Derivatives App 20170008895 - Bradner; James E. ; et al.	2017-01-12
Methods Of Stratifying Patients For Treatment With Retinoic Acid Receptor-alpha Agonists App 20160355888 - Chen; Mei Wei ; et al.	2016-12-08
Dihydropteridinone Derivatives And Uses Thereof App 20160347750 - Bradner; James E. ; et al.	2016-12-01
Diazepane Derivatives And Uses Thereof App 20160347749 - Bradner; James E. ; et al.	2016-12-01
Combination Therapy For Cancer Using Bromodomain And Extra-terminal (bet) Protein Inhibitors App 20160279141 - Bradner; James E. ; et al.	2016-09-29
Inhibitors Of Transcription Factors And Uses Thereof App 20160168154 - Marineau; Jason J. ; et al.	2016-06-16
Pyrrol-1-yl Benzoic Acid Derivatives Useful As Myc Inhibitors App 20150291521 - Bradner; James E. ; et al.	2015-10-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.